✦ LIBER ✦

A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients

✍ Scribed by Norkus, Darius; Karklelyte, Agata; Engels, Benedikt; Versmessen, Harijati; Griskevicius, Romas; De Ridder, Mark; Storme, Guy; Aleknavicius, Eduardas; Janulionis, Ernestas; Valuckas, Konstantinas

Book ID: 121620093
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 280 KB
Volume: 8
Category: Article
ISSN: 1748-717X
DOI: 10.1186/1748-717X-8-206

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 Study: Feasibility and Acute Tox

Phase 2 Study: Feasibility and Acute Toxicity of Dose-Escalated Hypofractionated Intensity Modulated Radiation Therapy With Concurrent Treatment of Pelvic Lymph Nodes in High-Risk Prostate Cancer Patients

✍ Drodge, S.; Boychak, A.; Patel, S.; Usmani, N.; Amanie, J.; Parliament, M.; Murt 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Analysis of toxicity in patients with hi

Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area

✍ Stefano Arcangeli; Biancamaria Saracino; Maria Grazia Petrongari; Sara Gomellini 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Single-Fraction High-Dose-Rate Brachythe

Single-Fraction High-Dose-Rate Brachytherapy and Hypofractionated External Beam Radiotherapy for Men With Intermediate-Risk Prostate Cancer: Analysis of Short- and Medium-Term Toxicity and Quality of Life

✍ Gerard C. Morton; D. Andrew Loblaw; Raxa Sankreacha; Andrea Deabreu; Liying Zhan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 259 KB

Rectal Dose–Volume Histogram Parameters

Rectal Dose–Volume Histogram Parameters Are Associated With Long-Term Patient-Reported Gastrointestinal Quality of Life After Conventional and High-Dose Radiation for Prostate Cancer: A Subgroup Analysis of a Randomized Trial

✍ Paul L. Nguyen; Ronald C. Chen; Karen E. Hoffman; Alexei Trofimov; Jason A. Efst 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 89 KB

A phase III trial of docetaxel–estramust

A phase III trial of docetaxel–estramustine in high-risk localised prostate cancer: A planned analysis of response, toxicity and quality of life in the GETUG 12 trial

✍ Karim Fizazi; Francois Lesaunier; Remy Delva; Gwenaëlle Gravis; Frederic Rolland 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 521 KB

4033 POSTER Preliminary results of late

4033 POSTER Preliminary results of late rectal and urinary toxicity in a phase II randomized study of conventional fractionation vs. hypofractionation on patients with high risk prostate cancer

✍ S. Gomellini; M.G. Petrongari; B.M. Saracino; S. Arcangeli; S. Marzi; V. Landoni 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 64 KB